Eric Benevich Net Worth & Insider Trades

Eric Benevich - Chief Commercial Officer, Neurocrine Biosciences Inc

As of February 9, 2022

What is Eric Benevich's Net Worth?

The current estimated net worth of Neurocrine Biosciences Inc's Chief Commercial Officer, Eric Benevich, is estimated to be about $9.94M . Eric Benevich owns about 20,338 units of Neurocrine Biosciences Inc common stock. In the last 7 years at Neurocrine Biosciences Inc, Eric Benevich has sold an estimated value of $8.28M worth.

What is Eric Benevich's Past Insider Trading?

Eric Benevich's largest purchase order was 20,595 units , worth over $741.21K on November 4, 2020. Eric Benevich's largest sale order was 20,595 units , worth over $1.99M on November 4, 2020. In total, Eric Benevich has made about 20 transactions over 7 years of their time at Neurocrine Biosciences Inc. Eric Benevich usually trades in February, with the busiest year in 2020. The most recent transaction was a sale order of 5,099 units , worth over $410.82K on February 9, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Eric Benevich's Salary in 2018?

As Chief Commercial Officer of Neurocrine Biosciences Inc, Eric Benevich has a total base salary of $432,600 . Eric Benevich received compensation valued at about $3,672,605 in 2018 after becoming Chief Commercial Officer. The vast majority of their compensation came in the form of a bonus of $205,485 , option awards of $1,496,335 , stock awards of $1,499,417 , and other compensation of $38,768 .

What is Eric Benevich's' Mailing Address?

  • Mailing address is C/o Neurocrine Biosciences, Inc. 12790 el Camino Real San Diego CA 92130 CA

Neurocrine Biosciences Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Stock Awards
Other Compensation
Total
Kevin C. Gorman, Ph.D. 2018 $675,000 $425,250 $4,486,852 $2,998,832 $47,045 $8,632,979
Kevin C. Gorman, Ph.D. 2019 $725,000 $667,000 $6,000,525 $2,000,071 $58,230 $9,450,826
Kevin C. Gorman, Ph.D. 2020 $775,000 $542,500 $7,124,633 $5,375,188 $63,311 $13,880,632
Matthew C. Abernethy 2018 $420,000 $199,500 - $1,996,506 $69,741 $2,685,747
Matthew C. Abernethy 2019 $495,600 $284,970 $3,750,345 $1,250,035 $42,170 $5,823,120
Matthew C. Abernethy 2020 $545,200 $190,820 $2,999,869 $2,500,266 $45,021 $6,281,176
Eric Benevich 2018 $432,600 $205,485 $1,496,335 $1,499,417 $38,768 $3,672,605
Eric Benevich 2019 $467,200 $280,320 $3,750,345 $1,250,035 $45,547 $5,793,447
Eric Benevich 2020 $499,900 $199,960 $2,999,869 $3,000,257 $48,974 $6,748,960
Kyle W. Gano, Ph.D. 2018 $403,100 $191,473 $1,309,024 $2,656,575 $8,069 $4,568,241
Kyle W. Gano, Ph.D. 2019 $443,400 $266,040 $3,000,285 $1,000,076 $16,171 $4,725,972
Kyle W. Gano, Ph.D. 2020 $487,700 $207,273 $3,749,799 $2,750,210 $16,751 $7,211,733
Eiry W. Roberts, M.D. 2018 $490,700 $220,800 $2,863,700 $4,053,869 $671,554 $8,300,623
Eiry W. Roberts, M.D. 2019 $538,200 $309,465 $3,000,285 $1,000,076 $51,889 $4,899,915
Eiry W. Roberts, M.D. 2020 $575,900 $215,963 $2,624,855 $2,375,242 $56,073 $5,848,033
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/914475/000119312521111693/d87247ddef14a.htm

What are Neurocrine Biosciences Inc's Past Insider Trades?

Neurocrine Biosciences Inc's most recent insider trade came on August 16, 2022 by Malcolm Lloydsmith who sold 21,533 units worth $2.28M . In the last 19 years, insiders at Neurocrine Biosciences Inc have sold an estimated value of $353.47M and bought an estimated value of $60.61M worth of shares. Insider trading is most common in May, with the busiest year in 2017. The most active traders at the company are Dimitri Grigoriadis, Chief Research Officer,  Gary Lyons, Director,  and Haig Bozigian, Chief Development Officer .

NEUROCRINE BIOSCIENCES INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1